PRURITUS Catriona Mayland July 2002. Topics Definition Neuroanatomy Mediators Evaluation General...

56
PRURITUS Catriona Mayland July 2002

Transcript of PRURITUS Catriona Mayland July 2002. Topics Definition Neuroanatomy Mediators Evaluation General...

Page 1: PRURITUS Catriona Mayland July 2002. Topics Definition Neuroanatomy Mediators Evaluation General treatment Systemic disorders Specific treatment.

PRURITUS

Catriona Mayland

July 2002

Page 2: PRURITUS Catriona Mayland July 2002. Topics Definition Neuroanatomy Mediators Evaluation General treatment Systemic disorders Specific treatment.

Topics

• Definition

• Neuroanatomy

• Mediators

• Evaluation

• General treatment

• Systemic disorders

• Specific treatment

Page 3: PRURITUS Catriona Mayland July 2002. Topics Definition Neuroanatomy Mediators Evaluation General treatment Systemic disorders Specific treatment.

Definition

• Unpleasant sensation causing desire to scratch

• Normally protective function

• Sensation arises from superficial skin, mucous membranes, conjunctiva

Page 4: PRURITUS Catriona Mayland July 2002. Topics Definition Neuroanatomy Mediators Evaluation General treatment Systemic disorders Specific treatment.

Neuroanatomy

• Nerve endings – dermo-epidermal junction

• Impulses – dorsal root ganglion

• Synapse in dorsal horn

• Efferents – contralateral spinothalamic tract

• Somatosensory cortex

• New concepts – peripheral & central mechanisms

Page 5: PRURITUS Catriona Mayland July 2002. Topics Definition Neuroanatomy Mediators Evaluation General treatment Systemic disorders Specific treatment.

Mediators

• Physical stimulation

• Chemical mediators– Amines e.g. histamine, serotonin, dopamine– Opiods e.g. met-enkephalin, -endorphin– Eicosanoids– Cytokines e.g. IL-1 to 11, TNF

Page 6: PRURITUS Catriona Mayland July 2002. Topics Definition Neuroanatomy Mediators Evaluation General treatment Systemic disorders Specific treatment.

And there’s more…

• Proteases e.g. tryptases, papain, kallikrein

• Growth Factor

• Neuropeptides– Substance P– CGRP, VIP, CCK– Bradykinin– Somatostatin, endothelin, neurokinin

Page 7: PRURITUS Catriona Mayland July 2002. Topics Definition Neuroanatomy Mediators Evaluation General treatment Systemic disorders Specific treatment.

Histamine

• Itching if applied to superficial damaged skin or injected intradermally

• Dermal mast cells

• Skin blood vessels, eccrine glands, basophils, hair follicles

Page 8: PRURITUS Catriona Mayland July 2002. Topics Definition Neuroanatomy Mediators Evaluation General treatment Systemic disorders Specific treatment.

Action

• Direct stimulation H receptors

• ? stimulation formulation other mediators

• Repeated injection – response decreases

• ? role in chronic itch

Page 9: PRURITUS Catriona Mayland July 2002. Topics Definition Neuroanatomy Mediators Evaluation General treatment Systemic disorders Specific treatment.

Serotonin

• Action– Direct on peripheral serotoninergic receptors– C-fibres via 5-HT3 receptors

Page 10: PRURITUS Catriona Mayland July 2002. Topics Definition Neuroanatomy Mediators Evaluation General treatment Systemic disorders Specific treatment.

Central Transmitters

• Endogenous opiods– Regulatory action– Both excitatory and modulatory effects– Inhibit presynaptic signals – modulate

secondary transmission– Abnormal central settings – directly trigger itch

despite no peripheral input

Page 11: PRURITUS Catriona Mayland July 2002. Topics Definition Neuroanatomy Mediators Evaluation General treatment Systemic disorders Specific treatment.

Other Mediators

• Exacerbate– Heat

– Anxiety

– Boredom

– Poor coping strategies

• Reduce– Cold

– Relaxation

– Distraction

– Good coping stategies

Page 12: PRURITUS Catriona Mayland July 2002. Topics Definition Neuroanatomy Mediators Evaluation General treatment Systemic disorders Specific treatment.

Evaluation

• Primary dermatological disease

• Systemic disease

• History and examination

• Drugs, onset, localised or systemic

Page 13: PRURITUS Catriona Mayland July 2002. Topics Definition Neuroanatomy Mediators Evaluation General treatment Systemic disorders Specific treatment.

Non-drug Treatments

• Discourage scratching – short nails

• Avoid hot baths, overheating and sweating

• Pat skin dry! Cool cotton clothes!

• Avoid alcohol and spicy foods

Page 14: PRURITUS Catriona Mayland July 2002. Topics Definition Neuroanatomy Mediators Evaluation General treatment Systemic disorders Specific treatment.

Skin Care

• Emollient – aqueous cream & menthol

• Calamine lotion - ?still recommended

• Barrier cream

• Consider hydrocortisone

• NB Eurax and topical antihistamines

Page 15: PRURITUS Catriona Mayland July 2002. Topics Definition Neuroanatomy Mediators Evaluation General treatment Systemic disorders Specific treatment.

Systemic Disorders

• Renal failure• Hepatogenic • Haematopoietic• Endocrine• Solid tumours• HIV

• Opiod induced• Neurogenic• Aquagenic• Inatrogenic• Senile• Psychogenic

Page 16: PRURITUS Catriona Mayland July 2002. Topics Definition Neuroanatomy Mediators Evaluation General treatment Systemic disorders Specific treatment.

Chronic Renal Failure

• Aetiology– Dry skin– Hyperparathyroidism– Mast cell proliferation– Loss opiod receptors and increased endogenous

opiods

Page 17: PRURITUS Catriona Mayland July 2002. Topics Definition Neuroanatomy Mediators Evaluation General treatment Systemic disorders Specific treatment.

• Peripheral neuropathy

• Increased – Histamine– Vitamin A– Magnesium, phosphate, aluminium– Serotonin– Substance P

Page 18: PRURITUS Catriona Mayland July 2002. Topics Definition Neuroanatomy Mediators Evaluation General treatment Systemic disorders Specific treatment.

Hepatogenic Pruritus

• PBC

• drug induced cholestasis– Oral contraceptive, phenothiazines

• Biliary obstruction

Page 19: PRURITUS Catriona Mayland July 2002. Topics Definition Neuroanatomy Mediators Evaluation General treatment Systemic disorders Specific treatment.

Aetiology

• ? Bile acids

• ? Accumulation pruritogen intermediary

• ? Histamine induced

• ? Centrally activated pruritogenic opiod

• ? Increased serotonin

Page 20: PRURITUS Catriona Mayland July 2002. Topics Definition Neuroanatomy Mediators Evaluation General treatment Systemic disorders Specific treatment.

Haematopoietic Disorders

• PCV– Increased histamine

• Hodgkins• Others

– ? Histamine– ? Autoimmune response– ? Infiltration – ? Release of leukopeptidase

Page 21: PRURITUS Catriona Mayland July 2002. Topics Definition Neuroanatomy Mediators Evaluation General treatment Systemic disorders Specific treatment.

Endocrine Disorders

• Thyrotoxicosis – ? Activate kinins– ? Reduced itch threshold

• Hypothyroidism– xerosis

• Diabetes mellitus– candida

Page 22: PRURITUS Catriona Mayland July 2002. Topics Definition Neuroanatomy Mediators Evaluation General treatment Systemic disorders Specific treatment.

Solid Tumours

• Paraneoplastic

• ? Allergic reaction to Ag

• ? Toxic products of necrotic tumour cells

• Breast, stomach, lung, prostrate, colon

Page 23: PRURITUS Catriona Mayland July 2002. Topics Definition Neuroanatomy Mediators Evaluation General treatment Systemic disorders Specific treatment.

Opiod Induced Pruritus

• Spinal > systemic

• Peripheral – stimulate release histamine

• Central – cephalad spread in CSF

• Bupivicaine given

• ? Role serotoninergic pathways

• ? Antagonism of inhibitory transmitters

• Opiod rotation

Page 24: PRURITUS Catriona Mayland July 2002. Topics Definition Neuroanatomy Mediators Evaluation General treatment Systemic disorders Specific treatment.

Inatrogenic Pruritus

• Aspirin

• Hydroxyurea

• Captopril

• Antibiotics

• Phenytoin

• Allopurinol

Page 25: PRURITUS Catriona Mayland July 2002. Topics Definition Neuroanatomy Mediators Evaluation General treatment Systemic disorders Specific treatment.

Neurogenic

• Neuropathies– E.g. multiple sclerosis– Activation artificial synapses

• Unilateral cerebral lesions– Effects on descending pathways

• Post-herpetic neuralgia

Page 26: PRURITUS Catriona Mayland July 2002. Topics Definition Neuroanatomy Mediators Evaluation General treatment Systemic disorders Specific treatment.

Senile Pruritus

• Xerosis

• Skin atropy

• ? Age associated degeneration in nerve endings

• ? Postmenopausal syndrome

Page 27: PRURITUS Catriona Mayland July 2002. Topics Definition Neuroanatomy Mediators Evaluation General treatment Systemic disorders Specific treatment.

Psychogenic Pruritus

• Feelings of hopelessness / helplessness

• Secretion serotonin, dopamine

• Elevated endogenous opiods

• ? ‘depressive equivalent’

Page 28: PRURITUS Catriona Mayland July 2002. Topics Definition Neuroanatomy Mediators Evaluation General treatment Systemic disorders Specific treatment.

Others

• HIV• High prevalence skin

disorders• Abnormal levels

cytokines• Hypereosinophilia• Peripheral neuropathy

• AQUAGENIC• Contact with water• Pathogenesis unknown

Page 29: PRURITUS Catriona Mayland July 2002. Topics Definition Neuroanatomy Mediators Evaluation General treatment Systemic disorders Specific treatment.

Specific Treatments

• Anti-inflammatory agents– Antihistamines

(cimetidine)

– Steroids

– Salicylates (capsacin)

– Thalidomide

• Central / peripheral nervous system agents– Antidepressants

– Anaesthetic agents

– Opiod antagonists

– Serotonin antagonists

– Neuroleptic agents

– Tranquillizers

Page 30: PRURITUS Catriona Mayland July 2002. Topics Definition Neuroanatomy Mediators Evaluation General treatment Systemic disorders Specific treatment.

Specific treatments

• Sequestrants– Cholestyramine

– Charcoal

– Heparin

• Vaso-active drugs– Alpha blockers

– Beta blockers

Page 31: PRURITUS Catriona Mayland July 2002. Topics Definition Neuroanatomy Mediators Evaluation General treatment Systemic disorders Specific treatment.

Disease Specific Interventions

• Cholestatic disease– Rifampicin

– Androgens

– Urso

– Stenting

• Uraemia– Erythropoitin

– UVB phototherapy

– Parathyroidectomy

– Transplantation

Page 32: PRURITUS Catriona Mayland July 2002. Topics Definition Neuroanatomy Mediators Evaluation General treatment Systemic disorders Specific treatment.

Disease Specific Interventions

• PCV – alpha interferon

• Fe deficiency – iron• Thyroid disorder

Page 33: PRURITUS Catriona Mayland July 2002. Topics Definition Neuroanatomy Mediators Evaluation General treatment Systemic disorders Specific treatment.

Miscellaneous

• Phototherapy

• TENS

• Acupuncture

• Psychotherapy

• Relaxation

Page 34: PRURITUS Catriona Mayland July 2002. Topics Definition Neuroanatomy Mediators Evaluation General treatment Systemic disorders Specific treatment.

Problems in Palliative Medicine

• Most terminal phase

• Changing organ function

• Systemic treatment may be toxic, impractical

Page 35: PRURITUS Catriona Mayland July 2002. Topics Definition Neuroanatomy Mediators Evaluation General treatment Systemic disorders Specific treatment.

Conclusions

• Pathophysiology not fully understood

• Peripheral and central mechanisms

• Often associated with systemic diseases

Page 36: PRURITUS Catriona Mayland July 2002. Topics Definition Neuroanatomy Mediators Evaluation General treatment Systemic disorders Specific treatment.

Conclusions

• Importance of non-pharmacological treatment

• Treat what is treatable

• Rare problem but impact on quality of life

• Likely that older drugs will be used

• Await our protocol review!

Page 37: PRURITUS Catriona Mayland July 2002. Topics Definition Neuroanatomy Mediators Evaluation General treatment Systemic disorders Specific treatment.

References

• Understanding pruritus in systemic disease– Journal Pain & Symptom Management 2001

• Pathophysiology of itching– Lancet 1996

• Oxford textbook of Palliative Medicine, Symptom Management in Advanced Cancer,Advanced Course in Pain & Symptom Management

Page 38: PRURITUS Catriona Mayland July 2002. Topics Definition Neuroanatomy Mediators Evaluation General treatment Systemic disorders Specific treatment.

Antihistamines

• Useful where histamine release has role

• E.g. allergic rhinoconjunctivitis

• Lack activity in CRF, haematopoitic disorders, opiod induced

• Pizotifen (antiserotoninergic action)

• Sedating doses e.g. hydroxyzine

Page 39: PRURITUS Catriona Mayland July 2002. Topics Definition Neuroanatomy Mediators Evaluation General treatment Systemic disorders Specific treatment.

Capsaicin

• Anti-inflammatory

• Reduces substance P from nerve endings

• Inhibits itch transmission

• Use : localised pruritus e.g. uraemia

Page 40: PRURITUS Catriona Mayland July 2002. Topics Definition Neuroanatomy Mediators Evaluation General treatment Systemic disorders Specific treatment.

Thalidomide

• Reduce TNF synthesis

• Anti-inflammatory

• ? Interfere with cytokine production

• Use : uraemia

Page 41: PRURITUS Catriona Mayland July 2002. Topics Definition Neuroanatomy Mediators Evaluation General treatment Systemic disorders Specific treatment.

Cimetidine

• Role not established

• Enhance effect anti-histamines

• Use : uraemia

haematological malignancies

Page 42: PRURITUS Catriona Mayland July 2002. Topics Definition Neuroanatomy Mediators Evaluation General treatment Systemic disorders Specific treatment.

Antidepressants

• Signs depression / anxiety

• Failure to respond to standard therapy

• Tricyclics (doxepin)– Antidepressant, antihistamine, sedative

• SSRI (paroxetine)– Down-regulation post-synaptic receptors– Reduce serotonin – receptor interaction

Page 43: PRURITUS Catriona Mayland July 2002. Topics Definition Neuroanatomy Mediators Evaluation General treatment Systemic disorders Specific treatment.

Role

• CRF

• Haematological malignancies

• Depressive disorders

• Neuroleptics / benzodiazepine use

Page 44: PRURITUS Catriona Mayland July 2002. Topics Definition Neuroanatomy Mediators Evaluation General treatment Systemic disorders Specific treatment.

5-HT3 Antagonists

• Ondansetron

• Serotonin mediator of itch

• Use : cholestasis, uraemia, spinal opiods

• Expensive

• Often IV use

Page 45: PRURITUS Catriona Mayland July 2002. Topics Definition Neuroanatomy Mediators Evaluation General treatment Systemic disorders Specific treatment.

Opiod Antagonists

• Counteract endogenous opiods

• Can be impractical

• Naltrexone (oral preparation)

• Use : CRF, hepatogenic & haematological pruritus

• ‘opiod abstinence syndrome’

Page 46: PRURITUS Catriona Mayland July 2002. Topics Definition Neuroanatomy Mediators Evaluation General treatment Systemic disorders Specific treatment.

• Buprenorphine

• Partial agonist

• Nalbuphine

• Mixed agonist-antagonist

• Needs further evaluation

• Opiod rotation

Page 47: PRURITUS Catriona Mayland July 2002. Topics Definition Neuroanatomy Mediators Evaluation General treatment Systemic disorders Specific treatment.

Anaesthetic Agents

• Lignocaine

• Abnormal pattern cutaneous innervation

• Associated peripheral neuropathy

• Use : uraemia

• Toxic adverse effects

Page 48: PRURITUS Catriona Mayland July 2002. Topics Definition Neuroanatomy Mediators Evaluation General treatment Systemic disorders Specific treatment.

• Propofol

• Subhypnotic doses in hepatogenic pruritus

• Opiod induced– ? Inhibit dorsal root transmission– ? Blocks

Page 49: PRURITUS Catriona Mayland July 2002. Topics Definition Neuroanatomy Mediators Evaluation General treatment Systemic disorders Specific treatment.

Sequestrants

• Cholestyramine

• Reduce bile acids

• Remove other pruritogens

• Use : cholestasis

• Unpalatable

• Diarrhoea

Page 50: PRURITUS Catriona Mayland July 2002. Topics Definition Neuroanatomy Mediators Evaluation General treatment Systemic disorders Specific treatment.

• Charcoal

• Use : uraemia

• ?chelates metabolites

• Heparin

Page 51: PRURITUS Catriona Mayland July 2002. Topics Definition Neuroanatomy Mediators Evaluation General treatment Systemic disorders Specific treatment.

Disease Specific Drugs

• Uraemia

• Erythropoietin

• UVB phototherapy

• Parathyroidectomy

• Transplantation

Page 52: PRURITUS Catriona Mayland July 2002. Topics Definition Neuroanatomy Mediators Evaluation General treatment Systemic disorders Specific treatment.

Disease Specific Drugs

• Cholestatic disease

• Androgens– Stanazol, methytestosterone

• Rifampicin

• Biliary stenting definitive treatment

Page 53: PRURITUS Catriona Mayland July 2002. Topics Definition Neuroanatomy Mediators Evaluation General treatment Systemic disorders Specific treatment.

Ultraviolet Light

• UVB

• Reduce content vitamin A

• Inhibit release histamine & proliferation mast cells

• Use : renal and liver disease, AIDS

Page 54: PRURITUS Catriona Mayland July 2002. Topics Definition Neuroanatomy Mediators Evaluation General treatment Systemic disorders Specific treatment.

• PUVA

• Ultrastructural changes in nerves

• Increase sensory thresholds

• Reduce end-organ responsiveness

• ? Stabilise mast cells

• Use : pruritic dermatoses

Page 55: PRURITUS Catriona Mayland July 2002. Topics Definition Neuroanatomy Mediators Evaluation General treatment Systemic disorders Specific treatment.

Others

• TENS– Induction on ‘lateral inhibition’ in spinal cord

• Acupuncture

• Plasma exchange

• Psychotherapy

• Relaxation

Page 56: PRURITUS Catriona Mayland July 2002. Topics Definition Neuroanatomy Mediators Evaluation General treatment Systemic disorders Specific treatment.